{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:41:23Z","timestamp":1790890883504,"version":"4.1.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005632","name":"Narodowe Centrum Bada\u0144 i Rozwoju","doi-asserted-by":"publisher","award":["0026\/2019-00"],"award-info":[{"award-number":["0026\/2019-00"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Axial spondyloarthritis (axSpA) is a chronic condition predominantly affecting the spine and sacroiliac joints. This article provides an in-depth overview of the current approaches to diagnosing, monitoring, and managing axSpA, including insights into developing terminology and diagnostic difficulties. A substantial portion of the debate focuses on the challenging diagnostic procedure, noting the difficulty of detecting axSpA early, particularly before the appearance of radiologic structural changes. Despite normal laboratory parameters, more than half of axSpA patients experience symptoms. X-ray and magnetic resonance imaging (MRI) are essential for evaluating structural damage and inflammation. MRI can be beneficial when there is no visible structural damage on X-ray as it can help unravel bone marrow edema (BME) as a sign of ongoing inflammation. The management covers both non-pharmacological and pharmacological approaches. Lifestyle modifications, physical activity, and patient education are essential components of the management. Pharmacological therapy, including nonsteroidal anti-inflammatory drugs (NSAIDs) and biologic disease-modifying anti-rheumatic drugs (bDMARDs), are explored, emphasizing individualized treatment. To effectively manage axSpA, a comprehensive and well-coordinated approach is necessary, emphasizing the significance of a multidisciplinary team. Telehealth applications play a growing role in axSpA management, notably in reducing diagnostic delays and facilitating remote monitoring. In conclusion, this article underlines diagnostic complexities\u00a0and emphasizes the changing strategy of axSpA treatment. The nuanced understanding offered here is designed to guide clinicians, researchers, and healthcare providers toward a more comprehensive approach to axSpA diagnosis and care.<\/jats:p>","DOI":"10.1007\/s00296-024-05615-3","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T13:01:45Z","timestamp":1715950905000},"page":"1395-1407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Diagnosis, monitoring, and management of axial spondyloarthritis"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-8486","authenticated-orcid":false,"given":"Olena","family":"Zimba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6065-8002","authenticated-orcid":false,"given":"Burhan Fatih","family":"Kocyigit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1749-9739","authenticated-orcid":false,"given":"Mariusz","family":"Korkosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,17]]},"reference":[{"key":"5615_CR1","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1136\/annrheumdis-2021-221035","volume":"80","author":"V Navarro-Comp\u00e1n","year":"2021","unstructured":"Navarro-Comp\u00e1n V, Sepriano A, El-Zorkany B, van der Heijde D (2021) Axial spondyloarthritis. Ann Rheum Dis 80:1511\u20131521. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221035","journal-title":"Ann Rheum Dis"},{"key":"5615_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368. https:\/\/doi.org\/10.1002\/art.1780270401","journal-title":"Arthritis Rheum"},{"key":"5615_CR3","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1007\/s00296-018-4130-1","volume":"38","author":"I Kucyba\u0142a","year":"2018","unstructured":"Kucyba\u0142a I, Urbanik A, Wojciechowski W (2018) Radiologic approach to axial spondyloarthritis: where are we now and where are we heading? Rheumatol Int 38:1753\u20131762. https:\/\/doi.org\/10.1007\/s00296-018-4130-1","journal-title":"Rheumatol Int"},{"key":"5615_CR4","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/art.20990","volume":"52","author":"M Rudwaleit","year":"2005","unstructured":"Rudwaleit M, Khan MA, Sieper J (2005) The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum 52:1000\u20131008. https:\/\/doi.org\/10.1002\/art.20990","journal-title":"Arthritis Rheum"},{"key":"5615_CR5","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/acr2.11044","volume":"1","author":"MA Khan","year":"2019","unstructured":"Khan MA, van der Linden S (2019) Axial Spondyloarthritis: A Better Name for an Old Disease: A Step Toward Uniform Reporting. ACR Open Rheumatol 1:336\u2013339. https:\/\/doi.org\/10.1002\/acr2.11044","journal-title":"ACR Open Rheumatol"},{"key":"5615_CR6","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1136\/ard.2009.108217","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Landew\u00e9 R, van der Heijde D et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 68:770\u2013776. https:\/\/doi.org\/10.1136\/ard.2009.108217","journal-title":"Ann Rheum Dis"},{"key":"5615_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s42358-020-00161-5","volume":"61","author":"G Citera","year":"2021","unstructured":"Citera G, Bautista-Molano W, Pel\u00e1ez-Ballestas I, Azevedo VF, Perich RA, M\u00e9ndez-Rodr\u00edguez JA, Cutri MS, Borlenghi CE (2021) Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis. Adv Rheumatol 61:2. https:\/\/doi.org\/10.1186\/s42358-020-00161-5","journal-title":"Adv Rheumatol"},{"key":"5615_CR8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1136\/annrheumdis-2013-204436","volume":"74","author":"F Costantino","year":"2015","unstructured":"Costantino F, Talpin A, Said-Nahal R, Goldberg M, Henny J, Chiocchia G, Garchon HJ, Zins M, Breban M (2015) Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort. Ann Rheum Dis 74:689\u2013693. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204436","journal-title":"Ann Rheum Dis"},{"key":"5615_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00296-019-04482-7","volume":"40","author":"M T\u0142ustochowicz","year":"2020","unstructured":"T\u0142ustochowicz M, Brzozowska M, Wierzba W, Raciborski F, Kwiatkowska B, T\u0142ustochowicz W, Jacyna A, Marczak M, Kisiel B, \u015aliwczy\u0144ski A (2020) Prevalence of axial spondyloarthritis in Poland. Rheumatol Int 40:323\u2013330. https:\/\/doi.org\/10.1007\/s00296-019-04482-7","journal-title":"Rheumatol Int"},{"key":"5615_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.berh.2018.10.006","volume":"32","author":"C L\u00f3pez-Medina","year":"2018","unstructured":"L\u00f3pez-Medina C, Molt\u00f3 A (2018) Update on the epidemiology, risk factors, and disease outcomes of axial spondyloarthritis. Best Pract Res Clin Rheumatol 32:241\u2013253. https:\/\/doi.org\/10.1016\/j.berh.2018.10.006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"5615_CR11","doi-asserted-by":"publisher","first-page":"e002174","DOI":"10.1136\/rmdopen-2021-002174","volume":"8","author":"A Boel","year":"2022","unstructured":"Boel A, van Lunteren M, L\u00f3pez-Medina C, Sieper J, van der Heijde D, van Gaalen FA (2022) Geographical prevalence of family history in patients with axial spondyloarthritis and its association with HLA-B27 in the ASAS-PerSpA study. RMD Open 8:e002174. https:\/\/doi.org\/10.1136\/rmdopen-2021-002174","journal-title":"RMD Open"},{"key":"5615_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jbspin.2015.02.006","volume":"82","author":"M Dougados","year":"2015","unstructured":"Dougados M, Etcheto A, Molto A et al (2015) Clinical presentation of patients suffering from recent onset chronic inflammatory back pain suggestive of spondyloarthritis: The DESIR cohort. Joint Bone Spine 82:345\u2013351. https:\/\/doi.org\/10.1016\/j.jbspin.2015.02.006","journal-title":"Joint Bone Spine"},{"key":"5615_CR13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/art.37803","volume":"65","author":"J Sieper","year":"2013","unstructured":"Sieper J, van der Heijde D (2013) Review: Nonradiographic axial spondyloarthritis: new definition of an old disease? Arthritis Rheum 65:543\u2013551. https:\/\/doi.org\/10.1002\/art.37803","journal-title":"Arthritis Rheum"},{"key":"5615_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2023.101871","volume":"37","author":"FA van Gaalen","year":"2023","unstructured":"van Gaalen FA, Rudwaleit M (2023) Challenges in the diagnosis of axial spondyloarthritis. Best Pract Res Clin Rheumatol 37:101871. https:\/\/doi.org\/10.1016\/j.berh.2023.101871","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"5615_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa250","author":"D Poddubnyy","year":"2020","unstructured":"Poddubnyy D (2020) Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/keaa250","journal-title":"Rheumatology"},{"key":"5615_CR16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/ard.2003.011247","volume":"63","author":"M Rudwaleit","year":"2004","unstructured":"Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J (2004) How to diagnose axial spondyloarthritis early. Ann Rheum Dis 63:535\u2013543. https:\/\/doi.org\/10.1136\/ard.2003.011247","journal-title":"Ann Rheum Dis"},{"key":"5615_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11926-020-00923-6","volume":"22","author":"R Adshead","year":"2020","unstructured":"Adshead R, Donnelly S, Knight P, Tahir H (2020) Axial Spondyloarthritis: Overcoming the Barriers to Early Diagnosis-an Early Inflammatory Back Pain Service. Curr Rheumatol Rep 22:59. https:\/\/doi.org\/10.1007\/s11926-020-00923-6","journal-title":"Curr Rheumatol Rep"},{"key":"5615_CR18","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1136\/ard.2005.051045","volume":"65","author":"M Rudwaleit","year":"2006","unstructured":"Rudwaleit M, Feldtkeller E, Sieper J (2006) Easy assessment of axial spondyloarthritis (early ankylosing spondylitis) at the bedside. Ann Rheum Dis 65:1251\u20131252. https:\/\/doi.org\/10.1136\/ard.2005.051045","journal-title":"Ann Rheum Dis"},{"key":"5615_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X20934277","author":"M Lorenzin","year":"2020","unstructured":"Lorenzin M, Ometto F, Ortolan A, Felicetti M, Favero M, Doria A, Ramonda R (2020) An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision. Ther Adv Musculoskelet Dis. https:\/\/doi.org\/10.1177\/1759720X20934277","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"5615_CR20","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1093\/rheumatology\/ket164","volume":"52","author":"R van den Berg","year":"2013","unstructured":"van den Berg R, de Hooge M, van Gaalen F, Reijnierse M, Huizinga T, van der Heijde D (2013) Percentage of patients with spondyloarthritis in patients referred because of chronic back pain and performance of classification criteria: experience from the Spondyloarthritis Caught Early (SPACE) cohort. Rheumatology (Oxford) 52:1492\u20131499. https:\/\/doi.org\/10.1093\/rheumatology\/ket164","journal-title":"Rheumatology (Oxford)"},{"key":"5615_CR21","first-page":"980","volume":"26","author":"A Spoorenberg","year":"1999","unstructured":"Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H, van der Tempel H, van der Linden S (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:980\u2013984","journal-title":"J Rheumatol"},{"key":"5615_CR22","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/acr.24174","volume":"73","author":"LC Coates","year":"2021","unstructured":"Coates LC, Baraliakos X, Blanco FJ et al (2021) The phenotype of axial spondyloarthritis: is it dependent on HLA-B27 status? Arthritis Care Res (Hoboken) 73:856\u2013860. https:\/\/doi.org\/10.1002\/acr.24174","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5615_CR23","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1002\/art.24024","volume":"58","author":"AN Bennett","year":"2008","unstructured":"Bennett AN, McGonagle D, O\u2019Connor P, Hensor EM, Sivera F, Coates LC, Emery P, Marzo-Ortega H (2008) Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 58:3413\u20133418. https:\/\/doi.org\/10.1002\/art.24024","journal-title":"Arthritis Rheum"},{"key":"5615_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/ard.2008.104018","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, Dougados M, Hermann KG, Landew\u00e9 R, Maksymowych W, van der Heijde D (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68:1\u201344. https:\/\/doi.org\/10.1136\/ard.2008.104018","journal-title":"Ann Rheum Dis"},{"key":"5615_CR25","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2014-206971","volume":"74","author":"P Mandl","year":"2015","unstructured":"Mandl P, Navarro-Comp\u00e1n V, Terslev L et al (2015) EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis 74:1327\u20131339. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206971","journal-title":"Ann Rheum Dis"},{"key":"5615_CR26","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1136\/annrheumdis-2012-201945","volume":"71","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy D, Brandt H, Vahldiek J, Spiller I, Song IH, Rudwaleit M, Sieper J (2012) The frequency of non-radiographic axial spondyloarthritis in relation to symptom duration in patients referred because of chronic back pain: results from the Berlin early spondyloarthritis clinic. Ann Rheum Dis 71:1998\u20132001. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201945","journal-title":"Ann Rheum Dis"},{"key":"5615_CR27","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1136\/annrheumdis-2016-210640","volume":"76","author":"T Diekhoff","year":"2017","unstructured":"Diekhoff T, Hermann KG, Greese J, Schwenke C, Poddubnyy D, Hamm B, Sieper J (2017) Comparison of MRI with radiography for detecting structural lesions of the sacroiliac joint using CT as standard of reference: results from the SIMACT study. Ann Rheum Dis 76:1502\u20131508. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210640","journal-title":"Ann Rheum Dis"},{"key":"5615_CR28","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1093\/rheumatology\/keaa155","volume":"59","author":"R Stal","year":"2020","unstructured":"Stal R, van Gaalen F, Sepriano A, Braun J, Reijnierse M, van den Berg R, van der Heijde D, Baraliakos X (2020) Facet joint ankylosis in r-axSpA: detection and 2-year progression on whole spine low-dose CT and comparison with syndesmophyte progression. Rheumatology (Oxford) 59:3776\u20133783. https:\/\/doi.org\/10.1093\/rheumatology\/keaa155","journal-title":"Rheumatology (Oxford)"},{"key":"5615_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1136\/annrheumdis-2021-220136","volume":"81","author":"T Diekhoff","year":"2022","unstructured":"Diekhoff T, Eshed I, Radny F, Ziegeler K, Proft F, Greese J, Deppe D, Biesen R, Hermann KG, Poddubnyy D (2022) Choose wisely: imaging for diagnosis of axial spondyloarthritis. Ann Rheum Dis 81:237\u2013242. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220136","journal-title":"Ann Rheum Dis"},{"key":"5615_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-023-05468-2","author":"YJ Lee","year":"2023","unstructured":"Lee YJ, Lee SH, Ahn SM, Hong S, Oh JS, Lee CK, Yoo B, Kim YG (2023) When MRI would be useful in patients without evidence of sacroiliitis on radiographs? Rheumatol Int. https:\/\/doi.org\/10.1007\/s00296-023-05468-2","journal-title":"Rheumatol Int"},{"key":"5615_CR31","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1136\/annrheumdis-2017-211486","volume":"76","author":"Z Ez-Zaitouni","year":"2017","unstructured":"Ez-Zaitouni Z, Bakker PA, van Lunteren M et al (2017) The yield of a positive MRI of the spine as imaging criterion in the ASAS classification criteria for axial spondyloarthritis: results from the SPACE and DESIR cohorts. Ann Rheum Dis 76:1731\u20131736. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211486","journal-title":"Ann Rheum Dis"},{"key":"5615_CR32","doi-asserted-by":"publisher","first-page":"e000586","DOI":"10.1136\/rmdopen-2017-000586","volume":"4","author":"C Lukas","year":"2018","unstructured":"Lukas C, Cyteval C, Dougados M, Weber U (2018) MRI for diagnosis of axial spondyloarthritis: major advance with critical limitations \u201cNot everything that glisters is gold (standard).\u201d RMD Open 4:e000586. https:\/\/doi.org\/10.1136\/rmdopen-2017-000586","journal-title":"RMD Open"},{"key":"5615_CR33","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1007\/s00296-019-04441-2","volume":"39","author":"R Almod\u00f3var","year":"2019","unstructured":"Almod\u00f3var R, Bueno \u00c1, Batlle E et al (2019) Magnetic resonance imaging assessment in patients with axial spondyloarthritis: development of checklists for use in clinical practice. Rheumatol Int 39:2119\u20132127. https:\/\/doi.org\/10.1007\/s00296-019-04441-2","journal-title":"Rheumatol Int"},{"key":"5615_CR34","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/art.40475","volume":"70","author":"J de Winter","year":"2018","unstructured":"de Winter J, de Hooge M, van de Sande M et al (2018) Magnetic Resonance Imaging of the Sacroiliac Joints Indicating Sacroiliitis According to the Assessment of SpondyloArthritis international Society Definition in Healthy Individuals, Runners, and Women With Postpartum Back Pain. Arthritis Rheumatol 70:1042\u20131048. https:\/\/doi.org\/10.1002\/art.40475","journal-title":"Arthritis Rheumatol"},{"key":"5615_CR35","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777\u2013783. https:\/\/doi.org\/10.1136\/ard.2009.108233","journal-title":"Ann Rheum Dis"},{"key":"5615_CR36","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1136\/annrheumdis-2015-208642","volume":"75","author":"RG Lambert","year":"2016","unstructured":"Lambert RG, Bakker PA, van der Heijde D et al (2016) Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group. Ann Rheum Dis 75:1958\u20131963. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208642","journal-title":"Ann Rheum Dis"},{"key":"5615_CR37","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/acr.22583","volume":"67","author":"R Aggarwal","year":"2015","unstructured":"Aggarwal R, Ringold S, Khanna D et al (2015) Distinctions between diagnostic and classification criteria? Arthritis Care Res (Hoboken) 67:891\u2013897. https:\/\/doi.org\/10.1002\/acr.22583","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5615_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210656","volume":"76","author":"RB Landew\u00e9","year":"2017","unstructured":"Landew\u00e9 RB, van der Heijde DM (2017) Why CAPS criteria are not diagnostic criteria? Ann Rheum Dis 76:e7. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210656","journal-title":"Ann Rheum Dis"},{"key":"5615_CR39","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/BOR.0000000000000402","volume":"29","author":"M Dubreuil","year":"2017","unstructured":"Dubreuil M, Deodhar AA (2017) Axial spondyloarthritis classification criteria: the debate continues. Curr Opin Rheumatol 29:317\u2013322. https:\/\/doi.org\/10.1097\/BOR.0000000000000402","journal-title":"Curr Opin Rheumatol"},{"key":"5615_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11926-015-0522-3","volume":"17","author":"R Landew\u00e9","year":"2015","unstructured":"Landew\u00e9 R, van Tubergen A (2015) Clinical Tools to Assess and Monitor Spondyloarthritis. Curr Rheumatol Rep 17:47. https:\/\/doi.org\/10.1007\/s11926-015-0522-3","journal-title":"Curr Rheumatol Rep"},{"key":"5615_CR41","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s10067-015-2949-3","volume":"34","author":"JD Reveille","year":"2015","unstructured":"Reveille JD (2015) Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. Clin Rheumatol 34:1009\u20131018. https:\/\/doi.org\/10.1007\/s10067-015-2949-3","journal-title":"Clin Rheumatol"},{"key":"5615_CR42","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1080\/03009742.2023.2213509","volume":"53","author":"C Michielsens","year":"2024","unstructured":"Michielsens C, Bolhuis TE, van Gaalen FA, van den Hoogen F, Verhoef LM, den Broeder N, den Broeder AA (2024) Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study. Scand J Rheumatol 53:180\u2013187. https:\/\/doi.org\/10.1080\/03009742.2023.2213509","journal-title":"Scand J Rheumatol"},{"key":"5615_CR43","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1136\/ard.2008.100826","volume":"68","author":"van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, Braun J, Landew\u00e9 R; Assessment of SpondyloArthritis international Society (ASAS)","year":"2009","unstructured":"van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, Braun J, Landew\u00e9 R; Assessment of SpondyloArthritis international Society (ASAS) (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811\u20131818. https:\/\/doi.org\/10.1136\/ard.2008.100826","journal-title":"Ann Rheum Dis"},{"key":"5615_CR44","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s00296-020-04662-w","volume":"40","author":"TG Sundaram","year":"2020","unstructured":"Sundaram TG, Muhammed H, Aggarwal A, Gupta L (2020) A prospective study of novel disease activity indices for ankylosing spondylitis. Rheumatol Int 40:1843\u20131849. https:\/\/doi.org\/10.1007\/s00296-020-04662-w","journal-title":"Rheumatol Int"},{"key":"5615_CR45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/ard.2010.138594","volume":"70","author":"Machado P, Landew\u00e9 R, Lie E, Kvien TK, Braun J, Baker D, van der Heijde D; Assessment of SpondyloArthritis international Society","year":"2011","unstructured":"Machado P, Landew\u00e9 R, Lie E, Kvien TK, Braun J, Baker D, van der Heijde D; Assessment of SpondyloArthritis international Society (2011) Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70:47\u201353. https:\/\/doi.org\/10.1136\/ard.2010.138594","journal-title":"Ann Rheum Dis"},{"key":"5615_CR46","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/annrheumdis-2017-212178","volume":"77","author":"A Molto","year":"2018","unstructured":"Molto A, Gossec L, Meghnathi B, Landew\u00e9 RBM, van der Heijde D, Atagunduz P, Elzorkany BK, Akkoc N, Kiltz U, Gu J, Wei JCC, Dougados M, ASAS-FLARE study group, (2018) An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS. Ann Rheum Dis 77:124\u2013127. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212178","journal-title":"Ann Rheum Dis"},{"key":"5615_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-004040","volume":"10","author":"V Navarro-Comp\u00e1n","year":"2024","unstructured":"Navarro-Comp\u00e1n V, Ramiro S, Deodhar A, Mease PJ, Rudwaleit M, de la Loge C, Fleurinck C, Taieb V, M\u00f8rup MF, Massow U, Kay J, Magrey M (2024) Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2. RMD Open 10:e004040. https:\/\/doi.org\/10.1136\/rmdopen-2023-004040","journal-title":"RMD Open"},{"key":"5615_CR48","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1136\/ard.2003.016717","volume":"63","author":"J Brandt","year":"2004","unstructured":"Brandt J, Listing J, Sieper J, Rudwaleit M, van der Heijde D, Braun J (2004) Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis. Ann Rheum Dis 63:1438\u20131444. https:\/\/doi.org\/10.1136\/ard.2003.016717","journal-title":"Ann Rheum Dis"},{"key":"5615_CR49","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1136\/ard.2005.040758","volume":"65","author":"Braun J, Davis J, Dougados M, Sieper J, van der Linden S, van der Heijde D; ASAS Working Group","year":"2006","unstructured":"Braun J, Davis J, Dougados M, Sieper J, van der Linden S, van der Heijde D; ASAS Working Group (2006) First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis 65:316\u2013320. https:\/\/doi.org\/10.1136\/ard.2005.040758","journal-title":"Ann Rheum Dis"},{"key":"5615_CR50","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13075-023-03173-w","volume":"25","author":"M Hallstr\u00f6m","year":"2023","unstructured":"Hallstr\u00f6m M, Klingberg E, Deminger A, Rehnman JB, Geijer M, Forsblad-d\u2019Elia H (2023) Physical function and sex differences in radiographic axial spondyloarthritis: a cross-sectional analysis on Bath Ankylosing Spondylitis Functional Index. Arthritis Res Ther 25:182. https:\/\/doi.org\/10.1186\/s13075-023-03173-w","journal-title":"Arthritis Res Ther"},{"key":"5615_CR51","doi-asserted-by":"publisher","first-page":"e001356","DOI":"10.1136\/rmdopen-2020-001356","volume":"6","author":"PD Carvalho","year":"2020","unstructured":"Carvalho PD, Ruyssen-Witrand A, Fonseca J, Marreiros A, Machado PM (2020) Determining factors related to impaired spinal and hip mobility in patients with axial spondyloarthritis: longitudinal results from the DESIR cohort. RMD Open 6:e001356. https:\/\/doi.org\/10.1136\/rmdopen-2020-001356","journal-title":"RMD Open"},{"key":"5615_CR52","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/acr.24500","volume":"74","author":"RL Biallas","year":"2022","unstructured":"Biallas RL, Dean LE, Davidson L, Hollick R, Pathan E, Robertson L, Jones GT, Macfarlane GJ, Rotariu O (2022) Role of metrology in axial spondyloarthritis: does it provide unique information in assessing patients and predicting outcome? results from the British society for rheumatology biologic register for ankylosing spondylitis. Arthritis Care Res (Hoboken) 74:665\u2013674. https:\/\/doi.org\/10.1002\/acr.24500","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5615_CR53","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s10067-015-3056-1","volume":"35","author":"MP Castro","year":"2016","unstructured":"Castro MP, Stebbings SM, Milosavljevic S, Bussey MD (2016) Construct validity of clinical spinal mobility tests in ankylosing spondylitis: a systematic review and meta-analysis. Clin Rheumatol 35:1777\u20131787. https:\/\/doi.org\/10.1007\/s10067-015-3056-1","journal-title":"Clin Rheumatol"},{"key":"5615_CR54","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/annrheumdis-2013-203967","volume":"74","author":"U Kiltz","year":"2015","unstructured":"Kiltz U, van der Heijde D, Boonen A et al (2015) Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS. Ann Rheum Dis 74:830\u2013835. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203967","journal-title":"Ann Rheum Dis"},{"key":"5615_CR55","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00296-016-3642-9","volume":"37","author":"M Di Carlo","year":"2017","unstructured":"Di Carlo M, Lato V, Di Matteo A, Carotti M, Salaffi F (2017) Defining functioning categories in axial Spondyloarthritis: the role of the ASAS Health Index. Rheumatol Int 37:713\u2013718. https:\/\/doi.org\/10.1007\/s00296-016-3642-9","journal-title":"Rheumatol Int"},{"key":"5615_CR56","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s00296-020-04680-8","volume":"40","author":"O Akgul","year":"2020","unstructured":"Akgul O, Bodur H, Ataman S, Yurdakul FG et al (2020) Clinical performance of ASAS Health Index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: real-world evidence from Multicenter Nationwide Registry. Rheumatol Int 40:1793\u20131801. https:\/\/doi.org\/10.1007\/s00296-020-04680-8","journal-title":"Rheumatol Int"},{"key":"5615_CR57","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1136\/ard.46.3.197","volume":"46","author":"M Mander","year":"1987","unstructured":"Mander M, Simpson JM, McLellan A, Walker D, Goodacre JA, Dick WC (1987) Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis 46:197\u2013202. https:\/\/doi.org\/10.1136\/ard.46.3.197","journal-title":"Ann Rheum Dis"},{"key":"5615_CR58","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/s0140-6736(02)08215-6","volume":"359","author":"J Braun","year":"2002","unstructured":"Braun J, Brandt J, Listing J et al (2002) Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 359:1187\u20131193. https:\/\/doi.org\/10.1016\/s0140-6736(02)08215-6","journal-title":"Lancet"},{"key":"5615_CR59","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1136\/ard.2007.084244","volume":"68","author":"WP Maksymowych","year":"2009","unstructured":"Maksymowych WP, Mallon C, Morrow S, Shojania K, Olszynski WP, Wong RL, Sampalis J, Conner-Spady B (2009) Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index. Ann Rheum Dis 68:948\u2013953. https:\/\/doi.org\/10.1136\/ard.2007.084244","journal-title":"Ann Rheum Dis"},{"key":"5615_CR60","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/art.23568","volume":"59","author":"PJ Healy","year":"2008","unstructured":"Healy PJ, Helliwell PS (2008) Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum 59:686\u2013691. https:\/\/doi.org\/10.1002\/art.23568","journal-title":"Arthritis Rheum"},{"key":"5615_CR61","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/ard.62.2.127","volume":"62","author":"L Heuft-Dorenbosch","year":"2003","unstructured":"Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, Landew\u00e9 R, van ver Tempel H, Mielants H, Dougados M, van der Heijde D, (2003) Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 62:127\u2013132. https:\/\/doi.org\/10.1136\/ard.62.2.127","journal-title":"Ann Rheum Dis"},{"key":"5615_CR62","first-page":"862","volume":"34","author":"C Lukas","year":"2007","unstructured":"Lukas C, Braun J, van der Heijde D, Hermann KG et al (2007) Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment. J Rheumatol 34:862\u2013870","journal-title":"J Rheumatol"},{"key":"5615_CR63","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/art.21445","volume":"53","author":"WP Maksymowych","year":"2005","unstructured":"Maksymowych WP, Inman RD, Salonen D, Dhillon SS, Williams M, Stone M, Conner-Spady B, Palsat J, Lambert RG (2005) Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis Rheum 53:703\u2013709. https:\/\/doi.org\/10.1002\/art.21445","journal-title":"Arthritis Rheum"},{"key":"5615_CR64","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/ard.2004.020503","volume":"64","author":"MC Creemers","year":"2005","unstructured":"Creemers MC, Franssen MJ, Vant Hof MA, Gribnau FW, Van de Putte LB, van Riel PL (2005) Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 64:127\u2013129. https:\/\/doi.org\/10.1136\/ard.2004.020503","journal-title":"Ann Rheum Dis"},{"key":"5615_CR65","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00296-021-04807-5","volume":"42","author":"M Cengiz","year":"2022","unstructured":"Cengiz M, Ataman \u015e, Sunar \u0130, Yal\u00e7\u0131n AP, Y\u0131lmaz G, Elhan AH (2022) Evaluation of the early cervical structural change in patients with non-radiographic axial spondyloarthropathy. Rheumatol Int 42:495\u2013502. https:\/\/doi.org\/10.1007\/s00296-021-04807-5","journal-title":"Rheumatol Int"},{"key":"5615_CR66","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2023","unstructured":"Ramiro S, Nikiphorou E, Sepriano A et al (2023) ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 82:19\u201334. https:\/\/doi.org\/10.1136\/ard-2022-223296","journal-title":"Ann Rheum Dis"},{"key":"5615_CR67","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/ard-2022-223297","volume":"82","author":"A Ortolan","year":"2023","unstructured":"Ortolan A, Webers C, Sepriano A, Falzon L, Baraliakos X, Landew\u00e9 RB, Ramiro S, van der Heijde D, Nikiphorou E (2023) Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS\/EULAR recommendations for the management of axial spondyloarthritis. Ann Rheum Dis 82:142\u2013152. https:\/\/doi.org\/10.1136\/ard-2022-223297","journal-title":"Ann Rheum Dis"},{"key":"5615_CR68","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/rheumatology\/keaa353","volume":"60","author":"F Hirano","year":"2021","unstructured":"Hirano F, van der Heijde D, van Gaalen FA, Landew\u00e9 RBM, Gaujoux-Viala C, Ramiro S (2021) Determinants of the patient global assessment of well-being in early axial spondyloarthritis: 5-year longitudinal data from the DESIR cohort. Rheumatology (Oxford) 60:316\u2013321. https:\/\/doi.org\/10.1093\/rheumatology\/keaa353","journal-title":"Rheumatology (Oxford)"},{"key":"5615_CR69","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1136\/annrheumdis-2014-205178","volume":"73","author":"S Ramiro","year":"2014","unstructured":"Ramiro S, van der Heijde D, van Tubergen A, Stolwijk C, Dougados M, van den Bosch F, Landew\u00e9 R (2014) Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann Rheum Dis 73:1455\u20131461. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205178","journal-title":"Ann Rheum Dis"},{"key":"5615_CR70","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1136\/ard.2008.091793","volume":"68","author":"R Landew\u00e9","year":"2009","unstructured":"Landew\u00e9 R, Dougados M, Mielants H, van der Tempel H, van der Heijde D (2009) Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine. Ann Rheum Dis 68:863\u2013867. https:\/\/doi.org\/10.1136\/ard.2008.091793","journal-title":"Ann Rheum Dis"},{"key":"5615_CR71","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1136\/annrheumdis-2018-213585","volume":"77","author":"AK Rausch Osthoff","year":"2018","unstructured":"Rausch Osthoff AK, Niedermann K, Braun J et al (2018) 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Ann Rheum Dis 77:1251\u20131260. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213585","journal-title":"Ann Rheum Dis"},{"key":"5615_CR72","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/annrheumdis-2014-206807","volume":"74","author":"HA Zangi","year":"2015","unstructured":"Zangi HA, Ndosi M, Adams J et al (2015) EULAR recommendations for patient education for people with inflammatory arthritis. Ann Rheum Dis 74:954\u2013962. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206807","journal-title":"Ann Rheum Dis"},{"key":"5615_CR73","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4081\/reumatismo.2015.853","volume":"67","author":"RC Ansell","year":"2015","unstructured":"Ansell RC, Shuto T, Busquets-Perez N, Hensor EM, Marzo-Ortega H, McGonagle D (2015) The role of biomechanical factors in ankylosing spondylitis: the patient\u2019s perspective. Reumatismo 67:91\u201396. https:\/\/doi.org\/10.4081\/reumatismo.2015.853","journal-title":"Reumatismo"},{"key":"5615_CR74","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1136\/annrheumdis-2015-208802","volume":"75","author":"S Tan","year":"2016","unstructured":"Tan S, Dasgupta A, Yao J, Flynn JA, Yao L, Ward MM (2016) Spatial distribution of syndesmophytes along the vertebral rim in ankylosing spondylitis: preferential involvement of the posterolateral rim. Ann Rheum Dis 75:1951\u20131957. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208802","journal-title":"Ann Rheum Dis"},{"key":"5615_CR75","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/annrheumdis-2021-222020","volume":"82","author":"JM Gwinnutt","year":"2023","unstructured":"Gwinnutt JM, Wieczorek M, Balanescu A et al (2023) 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases. Ann Rheum Dis 82:48\u201356. https:\/\/doi.org\/10.1136\/annrheumdis-2021-222020","journal-title":"Ann Rheum Dis"},{"key":"5615_CR76","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/art.33465","volume":"64","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy D, Haibel H, Listing J, M\u00e4rker-Hermann E, Zeidler H, Braun J, Sieper J, Rudwaleit M (2012) Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 64:1388\u20131398. https:\/\/doi.org\/10.1002\/art.33465","journal-title":"Arthritis Rheum"},{"key":"5615_CR77","doi-asserted-by":"publisher","first-page":"e000153","DOI":"10.1136\/rmdopen-2015-000153","volume":"1","author":"S Ramiro","year":"2015","unstructured":"Ramiro S, Landew\u00e9 R, van Tubergen A, Boonen A, Stolwijk C, Dougados M, van den Bosch F, van der Heijde D (2015) Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis. RMD Open 1:e000153. https:\/\/doi.org\/10.1136\/rmdopen-2015-000153","journal-title":"RMD Open"},{"key":"5615_CR78","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/rheumatology\/kew367","volume":"56","author":"X Baraliakos","year":"2017","unstructured":"Baraliakos X, Kiltz U, Peters S et al (2017) Efficiency of treatment with nonsteroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis. Rheumatology (Oxford) 56:95\u2013102. https:\/\/doi.org\/10.1093\/rheumatology\/kew367","journal-title":"Rheumatology (Oxford)"},{"key":"5615_CR79","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/art.21054","volume":"52","author":"A Wanders","year":"2005","unstructured":"Wanders A, Dv H, Landew\u00e9 R, B\u00e9hier JM, Calin A, Olivieri I, Zeidler H, Dougados M (2005) Nonsteroidal anti-inflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 52:1756\u20131765. https:\/\/doi.org\/10.1002\/art.21054","journal-title":"Arthritis Rheum"},{"key":"5615_CR80","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1136\/annrheumdis-2015-207897","volume":"75","author":"J Sieper","year":"2016","unstructured":"Sieper J, Listing J, Poddubnyy D, Song IH, Hermann KG, Callhoff J, Syrbe U, Braun J, Rudwaleit M (2016) Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS). Ann Rheum Dis 75:1438\u20131443. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207897","journal-title":"Ann Rheum Dis"},{"key":"5615_CR81","doi-asserted-by":"publisher","first-page":"e014591","DOI":"10.1136\/bmjopen-2016-014591","volume":"7","author":"F Proft","year":"2017","unstructured":"Proft F, Muche B, Listing J, Rios-Rodriguez V, Sieper J, Poddubnyy D (2017) Study protocol: Comparison of the effect of treatment with Nonsteroidal anti-inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti-tumour necrosis factor a therapy alone on progression of structural damage in the spine over two years in patients with ankylosing spondylitis (CONSUL)\u2014an open-label randomized controlled multicenter trial. BMJ Open 7:e014591. https:\/\/doi.org\/10.1136\/bmjopen-2016-014591","journal-title":"BMJ Open"},{"key":"5615_CR82","doi-asserted-by":"publisher","first-page":"e000397","DOI":"10.1136\/rmdopen-2016-000397","volume":"3","author":"A Regel","year":"2017","unstructured":"Regel A, Sepriano A, Baraliakos X, van der Heijde D, Braun J, Landew\u00e9 R, Van den Bosch F, Falzon L, Ramiro S (2017) Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS\/EULAR recommendations for the management of axial spondyloarthritis. RMD Open 3:e000397. https:\/\/doi.org\/10.1136\/rmdopen-2016-000397","journal-title":"RMD Open"},{"key":"5615_CR83","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11926-023-01097-7","volume":"25","author":"SR Harrison","year":"2023","unstructured":"Harrison SR, Marzo-Ortega H (2023) Have therapeutics enhanced our knowledge of axial spondyloarthritis? Curr Rheumatol Rep 25:56\u201367. https:\/\/doi.org\/10.1007\/s11926-023-01097-7","journal-title":"Curr Rheumatol Rep"},{"key":"5615_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000536601","volume":"1","author":"H Shentu","year":"2024","unstructured":"Shentu H, Sha S, He Y, He M, Dong N, Huang Z, Lai H, Chen M, Huang J, Huang X (2024) Efficacy of TNF-\u03b1 inhibitors in the treatment of nr-axSpA: a systematic review and meta-analysis based on randomized controlled trials. Int Arch Allergy Immunol 1:1\u201310. https:\/\/doi.org\/10.1159\/000536601","journal-title":"Int Arch Allergy Immunol"},{"key":"5615_CR85","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1136\/annrheumdis-2019-215427","volume":"78","author":"LM \u00d8rnbjerg","year":"2019","unstructured":"\u00d8rnbjerg LM, Brahe CH, Askling J et al (2019) Treatment response and drug retention rates in 24 195 biologic-na\u00efve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration. Ann Rheum Dis 78:1536\u20131544. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215427","journal-title":"Ann Rheum Dis"},{"key":"5615_CR86","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/art.24408","volume":"60","author":"N Barkham","year":"2009","unstructured":"Barkham N, Keen HI, Coates LC, O\u2019Connor P, Hensor E, Fraser AD, Cawkwell LS, Bennett A, McGonagle D, Emery P (2009) Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum 60:946\u2013954. https:\/\/doi.org\/10.1002\/art.24408","journal-title":"Arthritis Rheum"},{"key":"5615_CR87","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1080\/13543784.2021.2010187","volume":"30","author":"L Garcia-Montoya","year":"2021","unstructured":"Garcia-Montoya L, Emery P (2021) Disease modification in ankylosing spondylitis with TNF inhibitors: spotlight on early phase clinical trials. Expert Opin Investig Drugs 30:1109\u20131124. https:\/\/doi.org\/10.1080\/13543784.2021.2010187","journal-title":"Expert Opin Investig Drugs"},{"key":"5615_CR88","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13075-020-02208-w","volume":"22","author":"Y Yin","year":"2020","unstructured":"Yin Y, Wang M, Liu M, Zhou E, Ren T, Chang X, He M, Zeng K, Guo Y, Wu J (2020) Efficacy and safety of IL-17 inhibitors for the treatment of ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Res Ther 22:111. https:\/\/doi.org\/10.1186\/s13075-020-02208-w","journal-title":"Arthritis Res Ther"},{"key":"5615_CR89","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/art.40753","volume":"71","author":"A Deodhar","year":"2019","unstructured":"Deodhar A, Poddubnyy D, Pacheco-Tena C et al (2019) Efficacy and safety of ixekizumab in the treatment of radiographic axial spondyloarthritis: sixteen-week results from a phase III randomized, double-blind, placebo-controlled trial in patients with prior inadequate response to or intolerance of tumor necrosis factor inhibitors. Arthritis Rheumatol 71:599\u2013611. https:\/\/doi.org\/10.1002\/art.40753","journal-title":"Arthritis Rheumatol"},{"key":"5615_CR90","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1136\/annrheumdis-2020-219601","volume":"80","author":"A Deodhar","year":"2021","unstructured":"Deodhar A, Sliwinska-Stanczyk P, Xu H et al (2021) Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study. Ann Rheum Dis 80:1004\u20131013. https:\/\/doi.org\/10.1136\/annrheumdis-2020-219601","journal-title":"Ann Rheum Dis"},{"key":"5615_CR91","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/S0140-6736(19)32534-6","volume":"394","author":"D van der Heijde","year":"2019","unstructured":"van der Heijde D, Song IH, Pangan AL (2019) Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2\/3 trial. Lancet 394:2108\u20132117. https:\/\/doi.org\/10.1016\/S0140-6736(19)32534-6","journal-title":"Lancet"},{"key":"5615_CR92","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0140-6736(22)01212-0","volume":"400","author":"A Deodhar","year":"2022","unstructured":"Deodhar A, Van den Bosch F, Poddubnyy D et al (2022) Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 400:369\u2013379. https:\/\/doi.org\/10.1016\/S0140-6736(22)01212-0","journal-title":"Lancet"},{"key":"5615_CR93","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1136\/annrheumdis-2012-203055","volume":"73","author":"H Haibel","year":"2014","unstructured":"Haibel H, Fendler C, Listing J, Callhoff J, Braun J, Sieper J (2014) Efficacy of oral prednisolone in active ankylosing spondylitis: results of a double-blind, randomised, placebo-controlled short-term trial. Ann Rheum Dis 73:243\u2013246. https:\/\/doi.org\/10.1136\/annrheumdis-2012-203055","journal-title":"Ann Rheum Dis"},{"key":"5615_CR94","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.1093\/rheumatology\/keab275","volume":"60","author":"V Dhir","year":"2021","unstructured":"Dhir V, Mishra D, Samanta J (2021) Glucocorticoids in spondyloarthritis-systematic review and real-world analysis. Rheumatology (Oxford) 60:4463\u20134475. https:\/\/doi.org\/10.1093\/rheumatology\/keab275","journal-title":"Rheumatology (Oxford)"},{"key":"5615_CR95","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/1756-185X.14485","volume":"26","author":"KS Ma","year":"2023","unstructured":"Ma KS, Lee YH, Lin CJ, Shih PC, Wei JC (2023) Management of extra-articular manifestations in spondyloarthritis. Int J Rheum Dis 26:183\u2013186. https:\/\/doi.org\/10.1111\/1756-185X.14485","journal-title":"Int J Rheum Dis"},{"key":"5615_CR96","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00296-022-05136-x","volume":"42","author":"G Evangelatos","year":"2022","unstructured":"Evangelatos G, Bamias G, Kitas GD, Kollias G, Sfikakis PP (2022) The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era. Rheumatol Int 42:1493\u20131511. https:\/\/doi.org\/10.1007\/s00296-022-05136-x","journal-title":"Rheumatol Int"},{"key":"5615_CR97","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1136\/annrheumdis-2021-220420","volume":"80","author":"U Lindstr\u00f6m","year":"2021","unstructured":"Lindstr\u00f6m U, Bengtsson K, Olofsson T, Di Giuseppe D, Glintborg B, Forsblad-d\u2019Elia H, Jacobsson LTH, Askling J (2021) Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter? Ann Rheum Dis 80:1445\u20131452. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220420","journal-title":"Ann Rheum Dis"},{"key":"5615_CR98","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/annrheumdis-2018-214273","volume":"78","author":"S Schreiber","year":"2019","unstructured":"Schreiber S, Colombel JF, Feagan BG, Reich K, Deodhar AA, McInnes IB, Porter B, Das Gupta A, Pricop L, Fox T (2019) Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials. Ann Rheum Dis 78:473\u2013479. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214273","journal-title":"Ann Rheum Dis"},{"key":"5615_CR99","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1136\/annrheumdis-2019-215386","volume":"79","author":"PJ Mease","year":"2020","unstructured":"Mease PJ, Smolen JS, Behrens F et al (2020) A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-na\u00efve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial. Ann Rheum Dis 79:123\u2013131. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215386","journal-title":"Ann Rheum Dis"},{"key":"5615_CR100","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/S0140-6736(20)30564-X","volume":"395","author":"IB McInnes","year":"2020","unstructured":"McInnes IB, Behrens F, Mease PJ et al (2020) Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial. Lancet 395:1496\u20131505. https:\/\/doi.org\/10.1016\/S0140-6736(20)30564-X","journal-title":"Lancet"},{"key":"5615_CR101","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","volume":"74","author":"C Stolwijk","year":"2015","unstructured":"Stolwijk C, van Tubergen A, Castillo-Ortiz JD, Boonen A (2015) Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Rheum Dis 74:65\u201373. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203582","journal-title":"Ann Rheum Dis"},{"key":"5615_CR102","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2340\/16501977-1078","volume":"45","author":"I Kjeken","year":"2013","unstructured":"Kjeken I, B\u00f8 I, R\u00f8nningen A, Spada C, Mowinckel P, Hagen KB, Dagfinrud H (2013) A three-week multidisciplinary in-patient rehabilitation programme had positive long-term effects in patients with ankylosing spondylitis: randomized controlled trial. J Rehabil Med 45:260\u2013267. https:\/\/doi.org\/10.2340\/16501977-1078","journal-title":"J Rehabil Med"},{"key":"5615_CR103","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/art.42315","volume":"75","author":"J Rademacher","year":"2023","unstructured":"Rademacher J, M\u00fcllner H, Diekhoff T, Haibel H, Igel S, Pohlmann D, Proft F, Protopopov M, Rios Rodriguez V, Torgutalp M, Pleyer U, Poddubnyy D (2023) Keep an eye on the back: spondyloarthritis in patients with acute anterior uveitis. Arthritis Rheumatol 75:210\u2013219. https:\/\/doi.org\/10.1002\/art.42315","journal-title":"Arthritis Rheumatol"},{"key":"5615_CR104","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4103\/jpi.jpi_20_19","volume":"10","author":"MRF Aghdam","year":"2019","unstructured":"Aghdam MRF, Vodovnik A, Hameed RA (2019) Role of telemedicine in multidisciplinary team meetings. J Pathol Inform 10:35. https:\/\/doi.org\/10.4103\/jpi.jpi_20_19","journal-title":"J Pathol Inform"},{"issue":"2","key":"5615_CR105","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/1756-185X.14035","volume":"24","author":"P Das","year":"2021","unstructured":"Das P, Haldar R, Santhanam S (2021) Therapeutic exercises and rehabilitation in axial spondyloarthropathy: Balancing benefits with unique challenges in the Asia-Pacific countries. Int J Rheum Dis 24(2):170\u2013182. https:\/\/doi.org\/10.1111\/1756-185X.14035","journal-title":"Int J Rheum Dis"},{"key":"5615_CR106","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ejim.2021.07.005","volume":"93","author":"P Klemm","year":"2021","unstructured":"Klemm P, Preusler P, Hudowenz O, Asendorf T, M\u00fcller-Ladner U, Neumann E, Lange U, Tarner IH (2021) Multimodal rheumatologic complex treatment in patients with spondyloarthritis - a prospective study. Eur J Intern Med 93:42\u201349. https:\/\/doi.org\/10.1016\/j.ejim.2021.07.005","journal-title":"Eur J Intern Med"},{"key":"5615_CR107","doi-asserted-by":"publisher","first-page":"1759720X2097588","DOI":"10.1177\/1759720X20975888","volume":"12","author":"T Gudu","year":"2020","unstructured":"Gudu T, Jadon DR (2020) Multidisciplinary working in the management of axial and peripheral spondyloarthritis. Ther Adv Musculoskelet Dis 12:1759720X20975888","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"5615_CR108","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1002\/acr.24426","volume":"73","author":"M Garrido-Cumbrera","year":"2021","unstructured":"Garrido-Cumbrera M, Bundy C, Navarro-Comp\u00e1n V, Makri S, Sanz-G\u00f3mez S, Christen L, Mahapatra R, Delgado-Dom\u00ednguez CJ, Poddubnyy D (2021) Patient-reported impact of axial spondyloarthritis on working life: results from the european map of axial spondyloarthritis survey. Arthritis Care Res (Hoboken) 73:1826\u20131833. https:\/\/doi.org\/10.1002\/acr.24426","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5615_CR109","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s41927-023-00351-w","volume":"7","author":"N Wilson","year":"2023","unstructured":"Wilson N, Liu J, Adamjee Q, Di Giorgio S, Steer S, Hutton J, Lempp H (2023) Exploring the emotional impact of axial Spondyloarthritis: a systematic review and thematic synthesis of qualitative studies and a review of social media. BMC Rheumatol 7:26. https:\/\/doi.org\/10.1186\/s41927-023-00351-w","journal-title":"BMC Rheumatol"},{"key":"5615_CR110","doi-asserted-by":"publisher","first-page":"101689","DOI":"10.1016\/j.berh.2021.101689","volume":"35","author":"H So","year":"2021","unstructured":"So H, Tam LS (2021) Cardiovascular disease and depression in psoriatic arthritis: Multidimensional comorbidities requiring multidisciplinary management. Best Pract Res Clin Rheumatol 35:101689. https:\/\/doi.org\/10.1016\/j.berh.2021.101689","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"5615_CR111","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/1756-185X.14286","volume":"25","author":"S Ahmed","year":"2022","unstructured":"Ahmed S, Grainger R, Santosa A et al (2022) APLAR recommendations on the practice of telemedicine in rheumatology. Int J Rheum Dis 25:247\u2013258. https:\/\/doi.org\/10.1111\/1756-185X.14286","journal-title":"Int J Rheum Dis"},{"key":"5615_CR112","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s00296-021-04930-3","volume":"41","author":"A Mago","year":"2021","unstructured":"Mago A, Aggarwal V, Gupta L (2021) Telerheumatology and its interplay with patient-initiated care. Rheumatol Int 41:1883\u20131884. https:\/\/doi.org\/10.1007\/s00296-021-04930-3","journal-title":"Rheumatol Int"},{"key":"5615_CR113","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1136\/annrheumdis-2022-222341","volume":"81","author":"A de Thurah","year":"2022","unstructured":"de Thurah A, Bosch P, Marques A et al (2022) 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases. Ann Rheum Dis 81:1065\u20131071. https:\/\/doi.org\/10.1136\/annrheumdis-2022-222341","journal-title":"Ann Rheum Dis"},{"key":"5615_CR114","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00296-023-05360-z","volume":"44","author":"L Hannah","year":"2024","unstructured":"Hannah L, von Sophie R, Gabriella RM et al (2024) Stepwise asynchronous telehealth assessment of patients with suspected axial spondyloarthritis: results from a pilot study. Rheumatol Int 44:173\u2013180. https:\/\/doi.org\/10.1007\/s00296-023-05360-z","journal-title":"Rheumatol Int"},{"key":"5615_CR115","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s00296-023-05392-5","volume":"43","author":"S von Rohr","year":"2023","unstructured":"von Rohr S, Knitza J, Grahammer M, Schmalzing M, Kuhn S, Schett G, Ramming A, Labinsky H (2023) Student-led clinics and ePROs to accelerate diagnosis and treatment of patients with axial spondyloarthritis: results from a prospective pilot study. Rheumatol Int 43:1905\u20131911. https:\/\/doi.org\/10.1007\/s00296-023-05392-5","journal-title":"Rheumatol Int"},{"key":"5615_CR116","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3899\/jrheum.211116","volume":"49","author":"R Kempin","year":"2022","unstructured":"Kempin R, Richter JG, Schlegel A, Baraliakos X, Tsiami S, Buehring B, Kiefer D, Braun J, Kiltz U (2022) Monitoring of disease activity with a smartphone app in routine clinical care in patients with axial spondyloarthritis. J Rheumatol 49:878\u2013884. https:\/\/doi.org\/10.3899\/jrheum.211116","journal-title":"J Rheumatol"},{"key":"5615_CR117","doi-asserted-by":"publisher","first-page":"e002290","DOI":"10.1136\/rmdopen-2022-002290","volume":"8","author":"A Marques","year":"2022","unstructured":"Marques A, Bosch P, de Thurah A et al (2022) Effectiveness of remote care interventions: a systematic review informing the 2022 EULAR Points to Consider for remote care in rheumatic and musculoskeletal diseases. RMD Open 8:e002290. https:\/\/doi.org\/10.1136\/rmdopen-2022-002290","journal-title":"RMD Open"},{"key":"5615_CR118","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00296-023-05456-6","volume":"44","author":"L Paul","year":"2024","unstructured":"Paul L, McDonald MT, McConnachie A, Siebert S, Coulter EH (2024) Online physiotherapy for people with axial spondyloarthritis: quantitative and qualitative data from a cohort study. Rheumatol Int 44:145\u2013156. https:\/\/doi.org\/10.1007\/s00296-023-05456-6","journal-title":"Rheumatol Int"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05615-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05615-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05615-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T02:02:41Z","timestamp":1720058561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05615-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,17]]},"references-count":118,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["5615"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05615-3","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,17]]},"assertion":[{"value":"27 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conficts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}